During the recent session, TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s traded shares were 5.77 million, with the beta value of the company hitting -0.11. At the last check today, the stock’s price was $2.88, reflecting an intraday loss of -15.79% or -$0.54. The 52-week high for the TCBP share is $523.20, that puts it down -18066.67 from that peak though still a striking -10.42% loss since the share price plummeted to a 52-week low of $3.18. The company’s market capitalization is $0.09M, and the average intraday trading volume over the past 10 days was 0.11 million shares, and the average trade volume was 112.68K shares over the past three months.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

TC BioPharm (Holdings) plc ADR (TCBP) registered a -15.79% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -15.79% in intraday trading to $2.88, hitting a weekly high. The stock’s 5-day price performance is -38.13%, and it has moved by -68.68% in 30 days. Based on these gigs, the overall price performance for the year is -98.35%. The short interest in TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) is 38332.0 shares and it means that shorts have 0.02 day(s) to cover.

TCBP Dividends

TC BioPharm (Holdings) plc ADR is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders

Data provided on Aug 31, 2022 indicates that Trust For Professional Managers-PMC Diversified Equity Fund owns about 19.07 shares. This amounts to just over 0.05 percent of the company’s overall shares, with a $53390.0 market value.